Health economic issues of screening programmes
- 1 December 2003
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 162 (1) , S5-S7
- https://doi.org/10.1007/s00431-003-1341-5
Abstract
Economic evaluation supports decision making in health care in view of alternative courses of action and limited resources. It aims at providing maximum benefit in relation to invested resources. In the context of screening, it is required from an economical viewpoint that the cost of case finding, including confirmatory diagnostic tests and treatment, should be economically balanced in relation to possible expenditure on medical care as a whole. Costs of false-positive findings are crucial in newborn screening and pertain to direct costs (e.g. necessary diagnostic work-up), indirect costs (e.g. absence from work of parents) and intangible costs (e.g. anxiety and distress caused, stigmatisation).Keywords
This publication has 4 references indexed in Scilit:
- Cost-Benefit Analysis of Universal Tandem Mass Spectrometry for Newborn ScreeningPediatrics, 2002
- Newborn screening with tandem mass spectrometry: Examining its cost-effectiveness in the Wisconsin Newborn Screening PanelThe Journal of Pediatrics, 2002
- Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuriaJournal of Epidemiology and Community Health, 1999
- Neonatal screening for inborn errors of metabolism: cost, yield and outcome.Health Technology Assessment, 1997